Editorial of Special Issue "Multiple Sclerosis: Diagnosis and Treatment II"

被引:1
作者
Rivera, Victor M. [1 ]
机构
[1] Baylor Coll Med, Dept Neurol, One Baylor Plaza, Houston, TX 77030 USA
关键词
multiple sclerosis; acetylcholine; PBMCs; minority populations; spinal cord; sphingosine-1-phosphate modulators; neurofilaments light chain; biomarkers; microRNAs; child neurology;
D O I
10.3390/biomedicines9111605
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The special issue on Multiple Sclerosis: Diagnosis and Treatment II, reflects advances and discoveries in the molecular and cellular mechanisms of disease, and novel laboratory techniques providing more sensitivity to diagnostic techninques and the understanding of neuroinflammation. Mitochondrial-mediated apoptosis in isolated peripheral blood mononuclear cells and the role of reactive oxygen species are studied as indicators of activity of MS. In these cells, downregulation of circular and linera RNAs are reported as markers of highly active disease in MS. Progress and importance of Neurofilaments determinations in early diagnosis and as a marker of disease activity, and the analysis of the complex mechanisms and therapeutic potential of Sphingosine-1-phosphate receptor modulator are discussed. Epidemiologic observations from a highly diversified area of the world provide more insights into this important aspect of MS; discussions on the clinical challenges posed by spinal cord involvement in demyelinatind disorders and the latest aspects of pediatric onset MS, complement this fine collection of scientific papers.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Editorial: Cognition in Multiple Sclerosis
    Cortese, Rosa
    Carotenuto, Antonio
    Di Filippo, Massimiliano
    Lanzillo, Roberta
    [J]. FRONTIERS IN NEUROLOGY, 2021, 12
  • [42] Editorial: Preventing multiple sclerosis
    Dobson, Ruth
    Tanasescu, Radu
    Gran, Bruno
    [J]. FRONTIERS IN NEUROLOGY, 2022, 13
  • [43] Editorial: Fatigue in Multiple Sclerosis
    Dettmers, Christian
    DeLuca, John
    [J]. FRONTIERS IN NEUROLOGY, 2015, 6
  • [44] Personalized Treatment in Multiple Sclerosis
    Correale, Jorge
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2011, 11 (06) : 523 - 525
  • [45] Neuroprotection in the treatment of multiple sclerosis
    Zipp, F.
    Gold, R.
    [J]. NERVENARZT, 2011, 82 (08): : 973 - +
  • [46] Diagnosis of multiple sclerosis
    Miller, A
    [J]. SEMINARS IN NEUROLOGY, 1998, 18 (03) : 309 - 316
  • [47] Diagnosis of Multiple Sclerosis
    Giesser, Barbara S.
    [J]. NEUROLOGIC CLINICS, 2011, 29 (02) : 381 - +
  • [48] Personalized Treatment in Multiple Sclerosis
    Jorge Correale
    [J]. Current Neurology and Neuroscience Reports, 2011, 11 : 523 - 525
  • [49] Special issue on blood biomarkers in neurology Editorial for Special issue Blood biomarkers in Neurology
    Zelano, Johan
    Zetterberg, Henrik
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2022, 146 (04): : 323 - 324
  • [50] A Meta-Analytic Review of the Value of miRNA for Multiple Sclerosis Diagnosis
    Zhou, Zongpu
    Xiong, Huihui
    Xie, Fukang
    Wu, Zhongdao
    Feng, Ying
    [J]. FRONTIERS IN NEUROLOGY, 2020, 11